Law360, New York (March 12, 2007, 12:00 AM ET) -- The U.S. Food and Drug Administration reportedly met with a number of bile-duct stent manufacturers on Monday over alleged off-label uses of their products.
Meeting attendees were expected to include Boston Scientific Corp., Johnson & Johnson, Abbott Laboratories, ev3 Inc., C.R. Bard Inc. and Alveolus Inc., according to the Wall Street Journal.
A bile-duct, or biliary, stent is a plastic or metal device that props open the tubes that carry digestive fluids to the intestines. However, many doctors have also been using these stents to prop...
FDA Probes Off-Label Uses Of Drug-Coated Stents
To view the full article, take a free trial now.
